Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2024, Vol. 29 ›› Issue (8): 930-936.doi: 10.12092/j.issn.1009-2501.2024.08.010

Previous Articles     Next Articles

Research progresses of nonsense-mediated mRNA decay in tumorigenesis and cancer therapy

WANG Yuhui1, WANG Jingpeng2, CHEN Bei2, WANG Yaru2, LI Tangliang1,2   

  1. 1 School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou 311121, Zhejiang, China; 2 State Key Laboratory of Microbial Technology, Shandong University, Qingdao 266237, Shandong, China
  • Received:2023-12-20 Revised:2023-11-14 Online:2024-08-26 Published:2024-07-17

Abstract:

Nonsense-mediated mRNA decay (NMD) is a highly conserved post-transcriptional regulatory mechanism in eukaryotic cells. NMD can recognize and degrade abnormal transcripts containing premature termination codons (PTC) to prevent the translation of C-terminal truncated proteins. Furthermore, NMD could degrade a subset of normal gene transcripts and thus fine-tune gene expression. NMD is essential for cell fate determination, stress response, as well as animal development. In this review, we briefly discussed the functional and molecular mechanisms of NMD pathway activation and inhibition in tumorigenesis, cancer progression and therapy. Current studies indicate that NMD factor mutations can lead to a variety of human tumors. Interestingly, inhibition of NMD factors can activate DNA damage response and inhibit the expression of oncogenic factors, thereby killing cancer cells. This review may provide new perspectives for the biological mechanism and therapeutic strategy of human tumors.

Key words: nonsense-mediated mRNA decay, tumor, DNA damage response, inflammation

CLC Number: